Henry Schein (HSIC) : Wednesdays money flow data in Henry Schein (HSIC) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $5.07 million, whereas, $2.95 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.72, in favor of the bulls. The total money flow into the stock was $2.12 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $2.51 million. The total value of block trades done on upticks was $2.51 million. Henry Schein (HSIC) fell $0.74 and traded at $163.03, down -0.45% for the day, over previous days close. On a weekly basis, the shares are -0.86% over the previous weeks close.
Henry Schein, Inc. has lost 0.66% in the last five trading days and dropped 0.26% in the last 4 weeks. Henry Schein, Inc. has dropped 6.68% during the last 3-month period . Year-to-Date the stock performance stands at 3.55%.
Henry Schein (HSIC) : The consensus on Henry Schein (HSIC) based on 10 analyst recommendation on the company stock is 2, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 4 which endorses a Sell on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Henry Schein (NASDAQ:HSIC): The stock opened at $164.17 and touched an intraday high of $164.2525 on Wednesday. During the day, the stock corrected to an intraday low of $162.34, however, the bulls stepped in and pushed the price higher to close in the green at $163.8 with a gain of 0.02% for the day. The total traded volume for the day was 381,362. The stock had closed at $163.77 in the previous trading session.
Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Companys global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.